Laboratory Warning Signs
The hazard warning signage information collection process is changing permanently in January 2023. The old Laboratory Hazard Warning Sign Request Form was removed January 3, 2022 and ESSR is integrating signage request process into the BioRAFT system. The BioRAFT process will be the only way to request updates or new signage. Please see the BioRAFT Door Sign Tutorial detailed information on how to update your signage.
This integration will allow researchers to use the information they've already entered into BioRAFT, provide more inclusive hazard and precaution information, and expedite signage updates and replacement.
New signage holders will be installed by Facilities Management starting January 2023. All laboratories with current yellow hazard signage will be affected.
We will need research groups with affected spaces to:
- Assign person responsibility to manage signage changes in BioRAFT
- Identify three entrance/emergency contacts including both daytime and after-hours number
- Update hazard information specific to each space
Detailed coordination information will be provided to affected groups ahead of replacement efforts. Q&A/Assistance sessions will be scheduled to support labs completing the required items.
For more information, contact firstname.lastname@example.org.
- Hazard Warning Signage System - is designed to fulfill regulatory signage requirements as well as alert lab users and visitors to specific hazards located in individual laboratories.
- Supplemental sign for BSL2 animal rooms
- Conditions for removal of biohazard symbol
- All cultures, samples and biological waste have been removed from the laboratory.
- All cultures have been removed from storage in freezers and refrigerators.
- Laboratory benches, floors and equipment have been surface disinfected by lab personnel using effective disinfectant.
- PI does not plan to use the laboratory for BSL2 level research within the foreseeable future.
- PI has requested inactivation of his/her research registrations involving BSL2 agents